Antiretroviral therapy for prevention
ART lowers the concentration of HIV (also known as viral load) in the bloodstream and in genital secretions. Since viral load is the single greatest risk factor for all modes of HIV transmission, ART use decreases the risk that HIV will be transmitted from one person to another.
Modelling efforts over the past decade have examined the effects of antiretroviral therapy on HIV and TB prevention with varying proof of concept that antiretroviral drugs decrease HIV transmission comes from the prevention of mother to child transmission of HIV. Guidance also exists on the use of antiretroviral drugs for post-exposure prophylaxis to prevent HIV acquisition in HIV negative individuals, and research is ongoing on their use for pre-exposure prophylaxis.
Latest updates
-
22-27 July 2012
-
XIX International AIDS Conference: Turning the tide together
Washington DC, USA
-
XIX International AIDS Conference: Turning the tide together
-
18 July 2012
-
June 2012
-
Antiretroviral treatment as prevention of HIV and TB
Programmatic update
-
Antiretroviral treatment as prevention of HIV and TB
General information
- ART in HIV and TB prevention
-
Groundbreaking trial results confirm HIV treatment prevents transmission of HIV
12 May 2011 press release -
The strategic use of antiretrovirals for treatment and prevention of HIV infection: 2nd expert panel meeting
2-4 May 2012, Geneva, Switzerland